ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response.
J Immunother Cancer. 2022 Feb;10(2):e004232. doi: 10.1136/jitc-2021-004232.
J Immunother Cancer. 2022.
PMID: 35193933
Free PMC article.
Clinical Trial.